Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development

Dimitrios C Mastellos; Anna M Blom; E Sander Connolly; Mohamed R Daha; Brian V Geisbrecht; Berhane Ghebrehiwet; Piet Gros; George Hajishengallis; V Michael Holers; Markus Huber-Lang; Taroh Kinoshita; Tom E Mollnes; Robert A Montgomery; B Paul Morgan; Bo Nilsson; Ruben Pio; Daniel Ricklin; Antonio M Risitano; Ronald P Taylor; Alberto Mantovani; John P A Ioannidis; John D Lambris

doi:10.1038/s41590-019-0531-x

Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development

Dimitrios C Mastellos, Anna M Blom, E Sander Connolly, Mohamed R Daha, Brian V Geisbrecht, Berhane Ghebrehiwet, Piet Gros, George Hajishengallis, V Michael Holers, Markus Huber-Lang, Taroh Kinoshita, Tom E Mollnes, Robert A Montgomery, B Paul Morgan, Bo Nilsson, Ruben Pio, Daniel Ricklin, Antonio M Risitano, Ronald P Taylor, Alberto MantovaniJohn P A Ioannidis, John D Lambris

Sub Crystal and Structural Chemistry

Research output: Contribution to journal › Article › Academic

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original language	English
Pages (from-to)	1556
Journal	Nature Immunology
Volume	20
Issue number	11
DOIs	https://doi.org/10.1038/s41590-019-0531-x
Publication status	Published - Nov 2019

Access to Document

10.1038/s41590-019-0531-x

Cite this

Mastellos, D. C., Blom, A. M., Connolly, E. S., Daha, M. R., Geisbrecht, B. V., Ghebrehiwet, B., Gros, P., Hajishengallis, G., Holers, V. M., Huber-Lang, M., Kinoshita, T., Mollnes, T. E., Montgomery, R. A., Morgan, B. P., Nilsson, B., Pio, R., Ricklin, D., Risitano, A. M., Taylor, R. P., ... Lambris, J. D. (2019). Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development. Nature Immunology, 20(11), 1556. https://doi.org/10.1038/s41590-019-0531-x

@article{273843985d7a4de5a4d27df41736479a,

title = "Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development",

abstract = "An amendment to this paper has been published and can be accessed via a link at the top of the paper.",

author = "Mastellos, {Dimitrios C} and Blom, {Anna M} and Connolly, {E Sander} and Daha, {Mohamed R} and Geisbrecht, {Brian V} and Berhane Ghebrehiwet and Piet Gros and George Hajishengallis and Holers, {V Michael} and Markus Huber-Lang and Taroh Kinoshita and Mollnes, {Tom E} and Montgomery, {Robert A} and Morgan, {B Paul} and Bo Nilsson and Ruben Pio and Daniel Ricklin and Risitano, {Antonio M} and Taylor, {Ronald P} and Alberto Mantovani and Ioannidis, {John P A} and Lambris, {John D}",

year = "2019",

month = nov,

doi = "10.1038/s41590-019-0531-x",

language = "English",

volume = "20",

pages = "1556",

journal = "Nature Immunology",

issn = "1529-2908",

publisher = "Nature Publishing Group",

number = "11",

}

Mastellos, DC, Blom, AM, Connolly, ES, Daha, MR, Geisbrecht, BV, Ghebrehiwet, B, Gros, P, Hajishengallis, G, Holers, VM, Huber-Lang, M, Kinoshita, T, Mollnes, TE, Montgomery, RA, Morgan, BP, Nilsson, B, Pio, R, Ricklin, D, Risitano, AM, Taylor, RP, Mantovani, A, Ioannidis, JPA & Lambris, JD 2019, 'Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development', Nature Immunology, vol. 20, no. 11, pp. 1556. https://doi.org/10.1038/s41590-019-0531-x

TY - JOUR

T1 - Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development

AU - Mastellos, Dimitrios C

AU - Blom, Anna M

AU - Connolly, E Sander

AU - Daha, Mohamed R

AU - Geisbrecht, Brian V

AU - Ghebrehiwet, Berhane

AU - Gros, Piet

AU - Hajishengallis, George

AU - Holers, V Michael

AU - Huber-Lang, Markus

AU - Kinoshita, Taroh

AU - Mollnes, Tom E

AU - Montgomery, Robert A

AU - Morgan, B Paul

AU - Nilsson, Bo

AU - Pio, Ruben

AU - Ricklin, Daniel

AU - Risitano, Antonio M

AU - Taylor, Ronald P

AU - Mantovani, Alberto

AU - Ioannidis, John P A

AU - Lambris, John D

PY - 2019/11

Y1 - 2019/11

N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

AB - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

U2 - 10.1038/s41590-019-0531-x

DO - 10.1038/s41590-019-0531-x

M3 - Article

C2 - 31605100

SN - 1529-2908

VL - 20

SP - 1556

JO - Nature Immunology

JF - Nature Immunology

IS - 11

ER -

Author Correction: 'Stealth' corporate innovation: an emerging threat for therapeutic drug development

Abstract

Access to Document

Fingerprint

Cite this